CFO
Pfizer Inc (PFE)Board Member
Achieve Life Sciences, Inc. (ACHV)Equibles does not estimate personal net worth.
Get an email with a short summary when Tarsus Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get TARS alertsJeff Farrow is recorded as CFO at Tarsus Pharmaceuticals, Inc. (TARS), CFO at Pfizer Inc (PFE) and Board Member at Achieve Life Sciences, Inc. (ACHV) since May 29, 2026. Achieve Life Sciences, Inc. reported in an 8-K filed June 2, 2026 that Jeff Farrow was appointed director, effective May 29, 2026. Tarsus Pharmaceuticals, Inc. reported in an 8-K filed April 24, 2023 that Jeff Farrow was appointed Chief Financial Officer and Chief Strategy Officer, effective April 24, 2023. Jeff Farrow has spoken on 10 earnings calls and 5 other investor events across 1 company, most recently for Tarsus Pharmaceuticals, Inc. on August 6, 2026. Tarsus Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Achieve Life Sciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tarsus Pharmaceuticals, Inc. includes Bobak Azamian (CEO and Chairman), Jeffrey S. Farrow (CFO), Leonard Greenstein (CFO) and 7 others.
“On May 29, 2026, the Board of Directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”) appointed Jeff Farrow and Reid Waldman, M.D. (together, the “Incoming Directors”), as directors, effective as of such date.”
“The Company also announced the appointment of Jeff Farrow as the Company's Chief Financial Officer and Chief Strategy Officer, also effective as of the Transition Date.”
“All around, this was another outstanding quarter for Tarsus. We delivered RENIX STEMV revenue, continued expanding our leadership in eye care, and announced another important step in our long-term growth strategy through the acquisition of by Rennix, and today's announced pending acquisition of Alkiis.”
“So Tarsus is a commercial pharmaceutical company based in Orange County in Irvine, California, and we have a marketed product called Xtemvi for the treatment of demodex blephritis.”
“Perfect, thank you, Lachlan, and I appreciate the invitation to attend the meeting here. As Lachlan highlighted, we're Tarsus Pharmaceuticals.”
“I'll just quickly give an overview of Tarsus. So we are a commercial stage company. Our lead product is Xdenvi for the treatment of demodexplifitis. It's a disease of the eye.”
“I'll just quickly give an overview of Tarsus. So we are a commercial stage company. Our lead product is Xdenvi for the treatment of demodexplifitis. It's a disease of the eye.”
2026-05-29–present
Biotechnology · Healthcare
CFO
Biotechnology · Healthcare
Board Member
2026-05-29–present
